MedTrace Logo

Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas

NCT04216537 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2021-02-08

No results posted yet for this study

Summary

This study aims to collect clinical, radiological, pathological, molecular and genetic data including detailed clinical parameters, MR and histopathology images, molecular pathology and genetic data. This study seeks to find the prognostic and clinical significance based on molecular and genetic biomarkers/subgroups of gliomas.

Conditions

  • Glioma
  • Molecular Sequence Variation
  • Genetic Change

Interventions

DIAGNOSTIC_TEST

Glioma groups based on molecular pathology or genetic variation

Patients with newly diagnosed glioma that receive tumor resection

Sponsors & Collaborators

  • The First Affiliated Hospital of Zhengzhou University

    lead OTHER

Eligibility

Min Age
1 Year
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2025-01-01
Completion
2025-06-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04216537 on ClinicalTrials.gov